These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 28778333

  • 1. Access to Anti-osteoporosis Medication after Hip Fracture in Korean Elderly Patients.
    Yu YM, Lee JY, Lee E.
    Maturitas; 2017 Sep; 103():54-59. PubMed ID: 28778333
    [Abstract] [Full Text] [Related]

  • 2. Anti-osteoporosis medication treatment pattern after osteoporotic fracture during 2010-2016 in Fujian, China.
    Wang X, Li C, He Y, Wang T, Zhang H, Ma Z, Ma H, Zhao H.
    Arch Osteoporos; 2020 Aug 20; 15(1):134. PubMed ID: 32820451
    [Abstract] [Full Text] [Related]

  • 3. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality in elderly hip fracture patients: a prospective analysis.
    Nurmi-Lüthje I, Lüthje P, Kaukonen JP, Kataja M, Kuurne S, Naboulsi H, Karjalainen K.
    Drugs Aging; 2009 Aug 20; 26(5):409-21. PubMed ID: 19552493
    [Abstract] [Full Text] [Related]

  • 4. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.
    Castro-Lionard K, Dargent-Molina P, Fermanian C, Gonthier R, Cassou B.
    Drugs Aging; 2013 Dec 20; 30(12):1029-38. PubMed ID: 24114665
    [Abstract] [Full Text] [Related]

  • 5. Following hip fracture, hospital organizational factors associated with prescription of anti-osteoporosis medication on discharge, to address imminent refracture risk: a record-linkage study.
    Patel R, Judge A, Johansen A, Javaid MK, Griffin XL, Chesser T, Griffin J, Marques EMR, REDUCE Study Group , Ben-Shlomo Y, Gregson CL.
    J Bone Miner Res; 2024 Aug 21; 39(8):1071-1082. PubMed ID: 38988134
    [Abstract] [Full Text] [Related]

  • 6. Real-world effectiveness of anti-osteoporosis medications for the prevention of incident hip and clinical vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
    Iki M, Fujimori K, Nakatoh S, Tamaki J, Ishii S, Okimoto N, Kamiya K, Ogawa S.
    Bone; 2023 Jan 21; 166():116605. PubMed ID: 36347433
    [Abstract] [Full Text] [Related]

  • 7. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A, Lee E, Xue Z, Wutoh AK.
    Am J Geriatr Pharmacother; 2008 Dec 21; 6(5):240-8. PubMed ID: 19161926
    [Abstract] [Full Text] [Related]

  • 8. Screening and treatment of osteoporosis after hip fracture: comparison of sex and race.
    Antonelli M, Einstadter D, Magrey M.
    J Clin Densitom; 2014 Dec 21; 17(4):479-83. PubMed ID: 24657109
    [Abstract] [Full Text] [Related]

  • 9. Adherence to therapeutic and diagnostic recommendations in patients with femur fracture and at risk of re-fracture or death: results of an analysis of administrative databases.
    Degli Esposti L, Sinigaglia L, Rossini M, Adami S, Cagnoni C, Magliaro C, Veronesi C, Buda S, Minisola S.
    Reumatismo; 2012 Mar 16; 64(1):18-26. PubMed ID: 22472779
    [Abstract] [Full Text] [Related]

  • 10. Effects of anti-osteoporosis medications on total hip arthroplasty risks in osteoporotic patients with hip osteoarthritis in Taiwan: a nationwide cohort study.
    Hung CC, Wang CY, Fu SH, Yang RS, Hsiao FY.
    Arch Osteoporos; 2018 Oct 10; 13(1):107. PubMed ID: 30306268
    [Abstract] [Full Text] [Related]

  • 11. Delayed initiation of anti-osteoporosis medications increases subsequent hip and vertebral fractures in patients on long-term glucocorticoid therapy: A nationwide health insurance claims database study in Japan.
    Iki M, Fujimori K, Nakatoh S, Tamaki J, Ishii S, Okimoto N, Kamiya K, Ogawa S.
    Bone; 2022 Jul 10; 160():116396. PubMed ID: 35351673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study.
    Kim SC, Kim MS, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I, Peiró S, Lee J, Choi NK, Park BJ, Avorn J.
    Am J Med; 2015 May 10; 128(5):519-26.e1. PubMed ID: 25660252
    [Abstract] [Full Text] [Related]

  • 17. Forgetting the Frail: National Trends in Vitamin D Prescription After Fragility Fracture-A Large Insurance Claims Database Study.
    Liu AM, Mirle V, Lee C, Hynes K, Dirschl DR, Strelzow J.
    J Am Acad Orthop Surg; 2024 May 15; 32(10):464-471. PubMed ID: 38484091
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Secondary fracture prevention with osteoporosis medication after a fragility fracture in Sweden remains low despite new guidelines.
    Ek S, Meyer AC, Sääf M, Hedström M, Modig K.
    Arch Osteoporos; 2023 Jul 29; 18(1):107. PubMed ID: 37516714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.